Heterogeneity in hormone receptor status in primary and metastatic endometrial cancer
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 38 (3) , 437-441
- https://doi.org/10.1016/0090-8258(90)90087-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The distribution and prognostic implications of steroid receptors in endometrial carcinomasGynecologic Oncology, 1987
- Endometrial carcinoma: Steroid receptors and response to medroxyprogesterone acetateGynecologic Oncology, 1985
- Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1985
- Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin. Clinical correlatesCancer, 1982
- Hormone dependency of breast cancerCancer, 1981
- Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implicationsAmerican Journal of Obstetrics and Gynecology, 1981
- Clinical Correlates of Estrogen- and Progesterone-Binding Proteins in Human Endometrial AdenocarcinomaObstetrics & Gynecology, 1980
- Do Estrogen and Progesterone Receptors (E2R and PR) in Metastasizing Endometrial Cancers Predict the Response to Gestagen Therapy?Acta Obstetricia et Gynecologica Scandinavica, 1980
- Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapyInternational Journal of Cancer, 1979
- Progestational Agents in the Treatment of Carcinoma of the EndometriumNew England Journal of Medicine, 1961